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1. INTRODUCTION {#cam43286-sec-0005}
===============

Exposure to ultraviolet radiation during childhood is an important known risk factor for skin tumor, especially malignant melanoma, and has been shown in some but not all studies.[^1^](#cam43286-bib-0001){ref-type="ref"}, [^2^](#cam43286-bib-0002){ref-type="ref"}, [^3^](#cam43286-bib-0003){ref-type="ref"}, [^4^](#cam43286-bib-0004){ref-type="ref"} However, there is a paucity of data on the importance of exposure to ultraviolet radiation during early infancy. The few studies addressing this issue show conflicting results.[^5^](#cam43286-bib-0005){ref-type="ref"}, [^6^](#cam43286-bib-0006){ref-type="ref"}, [^7^](#cam43286-bib-0007){ref-type="ref"}, [^8^](#cam43286-bib-0008){ref-type="ref"}, [^9^](#cam43286-bib-0009){ref-type="ref"} It has been hypothesized that infants born during spring have a higher risk of skin tumors as they are exposed to ultraviolet radiation in a susceptible period compared to those born later in the year. However, the basis for the hypothesis and the methodological soundness of some of these studies has been questioned.[^5^](#cam43286-bib-0005){ref-type="ref"}, [^9^](#cam43286-bib-0009){ref-type="ref"}, [^10^](#cam43286-bib-0010){ref-type="ref"}, [^11^](#cam43286-bib-0011){ref-type="ref"} Also, as month of birth is not evenly distributed in the population it is of great importance to have full control of the population at risk.

We aimed to study the association between birth month and skin tumor in a cohort restricted to Caucasians in a national setting with high quality registers and completes coverage of person‐time at risk, cancer occurrence and follow‐up.

2. MATERIAL AND METHODS {#cam43286-sec-0006}
=======================

2.1. Study design {#cam43286-sec-0007}
-----------------

We conducted a population‐based cohort study of all individuals born in Sweden 1950 to 2014 (N = 7 245 453). Restricting the cohort to those born in Sweden to Swedish born parents or those born in neighboring Nordic countries helped ensure that individuals were most likely of Caucasian origin (N = 5 874 607). Information on date of birth, date of death and date of emigration was obtained from the Total Population Register.[^12^](#cam43286-bib-0012){ref-type="ref"} Occurrence of first skin tumor was obtained from the Swedish Cancer Register.[^13^](#cam43286-bib-0013){ref-type="ref"} We used the Multi‐Generation Register to identify the country of birth of the parents. Registers were linked using the unique personal identity number assigned to all Swedish residents. Subjects were followed until first diagnosis of skin tumor and censored on migration, death or end of study period (31 December 2015).

2.2. Exposure {#cam43286-sec-0008}
-------------

Date of birth for all 5.9 million individuals was categorized into birth month with March as the reference. Also, summer (June, July, August) was reference to spring (March, April, May), autumn (September, October, November), and winter (December, January, February) in the analyses of season of birth.

2.3. Outcome---Skin tumor {#cam43286-sec-0009}
-------------------------

Registration of all new primary malignancies is statutory in Sweden and the completeness of the Cancer Register is estimated to be high.[^13^](#cam43286-bib-0013){ref-type="ref"} Skin tumor diagnoses were defined using the International Statistical Classification of Diseases and Related Health Problems, Seventh Revision (ICD‐7), code 190‐191, corresponding to C43‐C44 in ICD‐10. The ICD‐7 revision was used because it was the only ICD version available in the Swedish Cancer register from 1960 throughout the whole study period. We included squamous cell carcinomas and melanomas, here after referred to as skin cancer/tumor. Basal cell carcinomas, despite being the by far most common cancer type, was excluded as it has only been routinely collected in the cancer register from 2004 and onwards in Sweden.

2.4. Covariates {#cam43286-sec-0010}
---------------

The year of birth was categorized in 5‐year calendar periods, 1950‐1954, 1955‐1959, 1960‐1964, 1965‐1969, 1970‐1974, 1975‐1979, 1980‐1984, 1985‐1989, 1990‐1994, 1995‐1999, 2000‐2004, 2005‐2009, 2010‐2014. Information on educational level at age 30 was ascertained from the Longitudinal Integration Database for Health Insurance and Labour Market Studies, held by Statistics Sweden. Highest attained educational level was categorized as: primary (ie less than 10 years of education), secondary (ie 10‐12 years of education), and tertiary (ie ≥13 years of education, corresponding to university education).

2.5. Statistical analyses {#cam43286-sec-0011}
-------------------------

We calculated age‐adjusted incidence rates by birth month for men and women separately, stratified by calendar period and by age at follow‐up. The distribution of birth month among skin tumor cases was compared to percentages of births per month and by percentages of person‐time at risk in the general population by birth months as ratios of observed to expected cases. Also, we estimated hazard ratios (HR) of skin tumor between strata of birth month by multivariable Cox regression, using age as timescale with 95% confidence intervals (95% CIs). Analyses were adjusted for sex and calendar year and additionally for education level where applicable. In sensitivity analyses we restricted the outcome to malignant melanoma cases only. Also, in a secondary analysis we used the same time period, reference (fall) and inclusion criteria as Crump et al[^6^](#cam43286-bib-0006){ref-type="ref"} and compared the results from a multivariable Cox regression with the results of logistic regression, as used in Crump et al[^6^](#cam43286-bib-0006){ref-type="ref"} analyzing those born between 1973 to 2008, including 3 795 592 subjects, and 1681 cases of skin tumor. Statistical analyses were conducted using STATA version 14.

3. RESULTS {#cam43286-sec-0012}
==========

The study population consisted of 5 874 607 individuals, including 3 018 521 men (51.4%) and 2 856 086 women (48.6%) yielding 99 032 088 and 93 0808 505 person‐years of follow‐up, respectively. Characteristics of the 33 914 skin tumor cases are shown in Table [1](#cam43286-tbl-0001){ref-type="table"}. Of the 33 914 cases of skin tumors, 3025 were squamous cell cancer, 16 968 malignant melanoma, 8493 melanoma in situ/other and 5428 squamous cell in situ/other. Incidence was higher in women and increased by age.

###### 

Characteristics of 33 914 skin tumor, and of which 25 597 malignant melanoma, in individuals born from 1950 to 2014, followed until 31 December 2015, in Sweden

  Birth year   All skin tumors                             Women                                       Melanoma                                    Women                                       Age at diagnosis                                                                                                                    
  ------------ ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- -------------------------------------------
  1950‐1954    9625                                        53.4                                        6073                                        53.5                                        54.1                                        9.5                                         6.7                                         65.9
  1955‐1959    7095                                        55.4                                        4938                                        55.9                                        49.3                                        9.0                                         6.5                                         60.9
  1960‐1964    5501                                        59.9                                        4268                                        60.9                                        44.7                                        8.3                                         1.5                                         55.8
  1965‐1969    4722                                        61.9                                        3970                                        61.8                                        40.6                                        7.5                                         0.3                                         50.8
  1970‐1974    3134                                        62.5                                        2790                                        63.1                                        36.2                                        6.8                                         1.3                                         45.6
  1975‐1979    1822                                        64.2                                        1676                                        64.9                                        32.5                                        5.7                                         4.5                                         40.8
  1980‐1984    968                                         65.4                                        912                                         65.2                                        28.9                                        4.3                                         7.0                                         35.6
  1985‐1989    658                                         68.2                                        624                                         68.1                                        24.9                                        3.4                                         10.3                                        30.7
  1990‐1994    287                                         66.6                                        260                                         66.2                                        20.6                                        2.8                                         3.2                                         25.7
  1995‐1999    81                                          54.3                                        70                                          57.1                                        17.0                                        2.9                                         2.9                                         20.8
  2000‐2004    15                                          73.3                                        11                                          72.7                                        9.5                                         4.3                                         0.7                                         14.7
  2005‐2009    5                                           [^a^](#cam43286-note-0002){ref-type="fn"}   5                                           [^a^](#cam43286-note-0002){ref-type="fn"}   6.4                                         2.3                                         3.3                                         8.8
  2010‐2014    [^a^](#cam43286-note-0002){ref-type="fn"}   [^a^](#cam43286-note-0002){ref-type="fn"}   [^a^](#cam43286-note-0002){ref-type="fn"}   [^a^](#cam43286-note-0002){ref-type="fn"}   [^a^](#cam43286-note-0002){ref-type="fn"}   [^a^](#cam43286-note-0002){ref-type="fn"}   [^a^](#cam43286-note-0002){ref-type="fn"}   [^a^](#cam43286-note-0002){ref-type="fn"}

Three cases or less.
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A crude comparison of observed to expected ratios of skin tumor cases by birth month showed the highest estimates in April for men and March for women, and the lowest in September for men and November for women. (Table [2](#cam43286-tbl-0002){ref-type="table"}).

###### 

Observed to expected ratio of skin tumor cases by month of birth. Expected cases are calculated for both the distribution of total person‐time and for the distribution of individuals born and alive at any time during follow‐up. Proportion of person‐time and births are calculated for men and women combined. Those born 1950 to 2014, followed until 31 December 2015, in Sweden

  Month     Observed   Expected by proportion person‐years   Expected by proportion individuals born                                                          
  --------- ---------- ------------------------------------- ----------------------------------------- -------- ------------------ --------- ------- -------- ------------------
  *Men*                                                                                                                                                       
  Jan       1206       8.51%                                 8.29%                                     1174.5   1.03 (0.97‐1.09)   249 126   8.24%   1167.4   1.03 (0.97‐1.09)
  Feb       1161       8.19%                                 8.13%                                     1152.1   1.01 (0.95‐1.07)   244 316   8.09%   1146.0   1.01 (0.95‐1.07)
  Mar       1340       9.46%                                 9.63%                                     1365.0   0.98 (0.93‐1.04)   287 190   9.48%   1342.5   1.00 (0.94‐1.05)
  Apr       1461       10.31%                                9.60%                                     1359.7   1.07 (1.02‐1.13)   285 449   9.44%   1337.5   1.09 (1.04‐1.15)
  May       1371       9.68%                                 9.28%                                     1314.5   1.04 (0.99‐1.10)   276 885   9.18%   1301.3   1.05 (1.00‐1.11)
  Jun       1160       8.19%                                 8.44%                                     1195.9   0.97 (0.91‐1.03)   256 242   8.50%   1203.7   0.96 (0.91‐1.02)
  Jul       1139       8.04%                                 8.38%                                     1188.0   0.96 (0.90‐1.02)   258 376   8.55%   1211.6   0.94 (0.89‐1.00)
  Aug       1115       7.87%                                 8.05%                                     1141.0   0.98 (0.92‐1.04)   248 305   8.26%   1169.8   0.95 (0.90‐1.01)
  Sep       1082       7.64%                                 8.08%                                     1144.5   0.95 (0.89‐1.00)   246 029   8.15%   1154.5   0.94 (0.88‐1.00)
  Oct       1082       7.64%                                 7.74%                                     1096.6   0.99 (0.93‐1.05)   234 281   7.80%   1105.1   0.98 (0.92‐1.04)
  Nov       971        6.85%                                 7.12%                                     1008.8   0.96 (0.90‐1.03)   214 536   7.12%   1009.0   0.96 (0.90‐1.03)
  Dec       1081       7.63%                                 7.26%                                     1028.5   1.05 (0.99‐1.12)   217 786   7.20%   1020.6   1.06 (1.00‐1.13)
  *Women*                                                                                                                                                     
  Jan       1622       8.21%                                 8.29%                                     1636.7   0.99 (0.94‐1.04)   234 874   8.24%   1626.8   1.00 (0.95‐1.05)
  Feb       1601       8.11%                                 8.13%                                     1605.6   1.00 (0.95‐1.05)   230 816   8.09%   1597.0   1.00 (0.95‐1.05)
  Mar       1984       10.05%                                9.63%                                     1902.1   1.04 (1.00‐1.09)   269 441   9.48%   1870.9   1.06 (1.01‐1.11)
  Apr       1896       9.60%                                 9.60%                                     1894.9   1.00 (0.96‐1.05)   269 092   9.44%   1863.9   1.02 (0.97‐1.07)
  May       1861       9.43%                                 9.28%                                     1831.8   1.02 (0.97‐1.06)   262 647   9.18%   1813.4   1.03 (0.98‐1.07)
  Jun       1678       8.50%                                 8.44%                                     1666.5   1.01 (0.96‐1.06)   242 818   8.50%   1677.4   1.00 (0.95‐1.05)
  Jul       1629       8.25%                                 8.38%                                     1655.5   0.98 (0.94‐1.03)   243 976   8.55%   1688.4   0.96 (0.92‐1.01)
  Aug       1537       7.78%                                 8.05%                                     1590.0   0.97 (0.92‐1.02)   236 708   8.26%   1630.2   0.94 (0.90‐0.99)
  Sep       1559       7.90%                                 8.08%                                     1594.9   0.98 (0.93‐1.03)   232 648   8.15%   1608.9   0.97 (0.92‐1.02)
  Oct       1538       7.79%                                 7.74%                                     1528.2   1.01 (0.96‐1.06)   223 898   7.80%   1540.0   1.00 (0.95‐1.05)
  Nov       1384       7.01%                                 7.12%                                     1405.8   0.98 (0.93‐1.04)   203 820   7.12%   1406.1   0.98 (0.93‐1.04)
  Dec       1456       7.37%                                 7.26%                                     1433.2   1.02 (0.96‐1.07)   205 348   7.20%   1422.2   1.02 (0.97‐1.08)
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Incidence of skin tumor by sex stratified by calendar birth period, presented by the first five years within each 10‐year calendar birth period, or age at follow‐up showed no difference between months of birth (Figures [1](#cam43286-fig-0001){ref-type="fig"} and [2](#cam43286-fig-0002){ref-type="fig"}). Subgroup analyses by sex, educational level, calendar period, or age at follow‐up similarly showed no association (data not shown).

![Crude rate of skin tumor by month of birth stratified by calendar birth period. Those born 1950‐2014](CAM4-9-6062-g001){#cam43286-fig-0001}

![Crude rate of skin tumor by month of birth stratified by age at follow up. Those born 1950‐2014](CAM4-9-6062-g002){#cam43286-fig-0002}

There was no association between month or season of birth and risk of skin tumor in the regression analyses. (Table [3](#cam43286-tbl-0003){ref-type="table"}). Also, restricting to malignant melanoma as outcome (N = 16 968) yielded no association with birth month (*P* = .682) (not shown). Mimicking the previous analyses on Swedish data by Crump et al,[^6^](#cam43286-bib-0006){ref-type="ref"} using same time period, reference (fall) and inclusion criteria on our data yielded a HR of 1.10 (0.96‐1.26) for Spring compared to an odds ratio of 1.20 (1.05‐1.37).

###### 

Incidence rate ratios and 95% confidence intervals for month of birth and season and risk of skin tumor in individuals born 1950‐2014 in Sweden, ages 0‐65 and followed for skin tumor from birth until 31 December 2015

  Month          Crude              Adjusted for sex and calendar birth year
  -------------- ------------------ ------------------------------------------
  Jan            0.98 (0.94,1.03)   0.98 (0.93,1.03)
  Feb            0.99 (0.94,1.04)   0.99 (0.94,1.04)
  Mar (ref)      1                  1
  Apr            1.02 (0.97,1.07)   1.02 (0.97,1.07)
  May            1.01 (0.96,1.06)   1.01 (0.97,1.06)
  Jun            0.99 (0.94,1.04)   1.00 (0.95,1.05)
  Jul            0.98 (0.93,1.03)   0.99 (0.94,1.04)
  Aug            0.99 (0.94,1.05)   1.00 (0.95,1.05)
  Sep            0.98 (0.93,1.03)   0.99 (0.94,1.04)
  Oct            1.01 (0.96,1.06)   1.02 (0.97,1.08)
  Nov            0.98 (0.93,1.03)   1.00 (0.95,1.05)
  Dec            1.03 (0.97,1.08)   1.05 (1.00,1.11)
  Season                            
  Winter         1.01 (0.98,1.04)   1.01 (0.98,1.04)
  Spring         1.02 (0.99,1.05)   1.01 (0.98,1.04)
  Summer (ref)   1                  1
  Autumn         1.00 (0.97,1.03)   1.01 (0.98,1.04)
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4. DISCUSSION {#cam43286-sec-0013}
=============

This large national register‐based study of 5.9 million individuals of Caucasian origin born from 1950 to 2014 showed no association between birth month and later risk of skin tumors. Our negative findings support a similarly large study from Germany showing no association.[^9^](#cam43286-bib-0009){ref-type="ref"} However, in contrast, three previous studies found an association between month of birth and malignant melanoma.[^5^](#cam43286-bib-0005){ref-type="ref"}, [^6^](#cam43286-bib-0006){ref-type="ref"}, [^7^](#cam43286-bib-0007){ref-type="ref"}

The main strengths of this study include the total population‐based cohort design, the large sample size, the complete nationwide coverage of the study exposures (birth month), outcome (skin tumor) and covariates and complete follow‐up using valid national Swedish registers with negligible missing data. Also, restricting the study population to those born in Sweden to Nordic born parents ensured that the vast majority of the study population was of Caucasian origin known to have a higher risk of skin tumors.[^14^](#cam43286-bib-0014){ref-type="ref"}, [^15^](#cam43286-bib-0015){ref-type="ref"} A limitation could be that we do not know if parents with high health awareness, including use of sun‐protection, chose not to have children born during seasons of high sun exposure (spring and summer). However, we think this is of minor importance, also it is not so easy to plan a pregnancy and date of delivery.

There is an on‐going debate on the most appropriate methodology to test the hypothesis that birth month is associated with increased risk of skin tumors in adulthood.[^5^](#cam43286-bib-0005){ref-type="ref"}, [^6^](#cam43286-bib-0006){ref-type="ref"}, [^7^](#cam43286-bib-0007){ref-type="ref"}, [^8^](#cam43286-bib-0008){ref-type="ref"}, [^9^](#cam43286-bib-0009){ref-type="ref"}, [^10^](#cam43286-bib-0010){ref-type="ref"}, [^11^](#cam43286-bib-0011){ref-type="ref"} It is essential to allocate the correct person‐time at risk by incorporating information on the distribution of birth month in the general population. In Sweden, the spring months have the highest number of births although this seasonal pattern of birth has attenuated in recent decades. We used birth month available for all subjects as the exposure and in a regression analyzed the estimates for each month with March as the reference. Hence, we have adequately categorized the exposure for all individuals.

Previous studies that reported an association were considerably smaller: 210, 1745 and 1595, melanoma cases, respectively.[^5^](#cam43286-bib-0005){ref-type="ref"}, [^6^](#cam43286-bib-0006){ref-type="ref"}, [^7^](#cam43286-bib-0007){ref-type="ref"} One of these studies, also from Sweden, partly overlaps with our study population.[^6^](#cam43286-bib-0006){ref-type="ref"} This study included all persons born from 1973 and onwards, whereas we studied those born between 1950 and 2014. They found an association between spring birth and cutaneous malignant melanoma (OR 1.21, 95% CI 1.05‐1.39, reference fall) in the very young (maximum age 37). However, restricting our analyses to the criteria used in Crump et al[^6^](#cam43286-bib-0006){ref-type="ref"} yielded a HR of 1.10 (0.96‐1.26) for Spring using Cox regression compared to an odds ratio of 1.20 (1.05‐1.37) using logistic regression as done by Crump et al. The odds ratio using our data is very close to the one presented by Crump et al,[^6^](#cam43286-bib-0006){ref-type="ref"} hence we argue that the different interpretations of the findings may in part be due to the statistical model used for analyses. We used Cox regression to account for person time at risk.

The negative findings in a large German study analyzed 28 374 melanoma cases of all ages.[^8^](#cam43286-bib-0008){ref-type="ref"}, [^9^](#cam43286-bib-0009){ref-type="ref"} The most appropriate age spans to study remain unclear. One could argue that early exposure to ultraviolet radiation should induce cancer to develop in young adulthood. Sun exposure during childhood has been shown to increase the risk for later skin tumors.[^3^](#cam43286-bib-0003){ref-type="ref"} However, skin tumors are rare in young adults making results susceptible to random variation.

The hypothesis tested is the assumption that infants born in spring are more exposed to strong ultraviolet radiation in a susceptible period of life. In Sweden there are guidelines explicitly recommending avoidance of direct sun light for children below one year of age.[^16^](#cam43286-bib-0016){ref-type="ref"} Thus, most parents are probably very reluctant to expose their newborn infants to direct sun. However, in other parts of the world intentional direct sun exposure in infancy is a concern.[^17^](#cam43286-bib-0017){ref-type="ref"}, [^18^](#cam43286-bib-0018){ref-type="ref"}, [^19^](#cam43286-bib-0019){ref-type="ref"} Sunbathing in Sweden has increased over the last decades with a large part of the population repeatedly exposed to strong ultraviolet radiation during holidays in Southern Europe, South East Asia and Northern Africa. The incidence of malignant melanoma is increasing steadily as observed in our study and with a graded manner (with increasing HR) for later birth cohorts compared to the earliest birth cohort born in 1960 in this study. Thus, the increase in exposure to ultraviolet radiation in childhood, adolescence and adulthood, unrelated to birth month and exposure in very early infancy, in later time periods could have impact on the risk of skin tumors for susceptible individuals also exposed during infancy. This increase in exposure together with changes in the Ozone layer probably would dilute any effect, if there is one, of month of birth.

In conclusion, we found no association between birth month and later development of skin tumor in a large national cohort study of nearly six million individuals with complete information on exposure, outcome and person‐time at risk.
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